Skip to main content

Gestational diabetes and pregnancy

Devices and technology

02-06-2023 | Type 1 diabetes | News

Pregnancy-specific closed-loop system proves feasible for home use

Results of a pilot study show that a hybrid closed-loop insulin delivery system customized for pregnancy used by women with type 1 diabetes at home significantly improved their glucose outcomes.

Blood sugar check in pregnancy

15-06-2020 | ADA 2020 | Conference coverage | News

Impaired hypoglycemia awareness linked to severe hypoglycemia during pregnancy

Impaired awareness of hypoglycemia is associated with an increased risk for severe hypoglycemia and increased fear of hypoglycemia in pregnant women with type 1 diabetes, shows a post-hoc analysis of CONCEPTT data.

05-11-2019 | Pregnancy | News

Breastfeeding study informs on insulin pump settings after childbirth

A small Danish study in breastfeeding women with long-term type 1 diabetes could provide useful information on which insulin pump settings to use after childbirth.

05-07-2019 | Continuous glucose monitoring | News

ATTD consensus group releases time in range recommendations

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

08-03-2019 | Pregnancy | DUKPC 2019 | News

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

Lori Berard, Pratik Choudhary

15-02-2019 | Inpatient diabetes | Video | Article

Diabetes device use in women admitted to the maternity ward

With the use of insulin pumps and related technologies expected to increase among pregnant women with type 1 diabetes, Pratik Choudhary and Lori Berard discuss management protocols for women admitted to maternity units (4:26).

07-11-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

13-06-2018 | Neonatal diabetes | Review | Article

Congenital diabetes: Comprehensive genetic testing allows for improved diagnosis and treatment of diabetes and other associated features

Letourneau LR, Greeley SAW. Curr Diab Rep 2018; 18: 46. doi: 10.1007/s11892-018-1016-2

Stethoscope on computer keyboard

24-05-2018 | Devices and technology | Review | Article

Telemedicine in complex diabetes management

McDonnell ME. Curr Diab Rep 2018; 18: 42. doi: 10.1007/s11892-018-1015-3

27-03-2018 | Pregnancy | News

Closed-loop insulin delivery shows promise in pregnancy

A small study suggests that closed-loop insulin delivery can produce equivalent glycemic control to that of sensor-augmented pump delivery, but with less hypoglycemia, during 1 month of use by pregnant women with type 1 diabetes.

06-02-2018 | Pregnancy | Review | Article

Caring for pregnant women whose diabetes antedates pregnancy: Is there room for improvement?

Sacks DA, Feig DS. Diabetologia 2018; Advance online publication. doi: 10.1007/s00125-018-4565-7

Abbott Freestyle Libre

19-12-2017 | Pregnancy | Case report | Article

Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: A case report

Kishimoto M, Tamada S, Oshiba Y. J Diabetes Metab Disord 2017; 16: 44. doi: 10.1186/s40200-017-0327-1

07-11-2017 | Pregnancy | News

October Cochrane review round-up

The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.

Harold de Valk

20-09-2017 | Pregnancy | EASD 2017 | Article

Expert commentary: The CONCEPTT trial

Harold de Valk discusses the importance of the CONCEPTT trial results for pregnant women with type 1 diabetes (3:08).
Read the accompanying news story

15-09-2017 | Continuous glucose monitoring | EASD 2017 | News

CGM use during pregnancy improves maternal glycemic control, neonatal outcomes

The CONCEPTT trial results suggest that the use of continuous glucose monitoring by pregnant women with type 1 diabetes improves glycemic control and neonatal outcomes relative to standard glucose monitoring.

04-08-2017 | Gestational diabetes | News

Women with gestational diabetes are failing to self-monitor

More than a third of women with gestational diabetes are failing to self-monitor their postprandial blood glucose levels, with possible implications for pregnancy outcomes, according to a French pilot study.